International Multicentre Prevalence Study on Sepsis (IMPRESS)
To mark 10 years of the Surviving Sepsis Campaign (SSC), and timed to coincide with World Sepsis Day, on September 13, 2013, the SSC, ESICM and SCCM will be conducting an international point prevalence study of severe sepsis and septic shock. The goal of this project is to determine the world wide burden of severe sepsis and define current practices of sepsis care internationally. The study is a simple data collection exercise for patients presenting with either severe sepsis or septic shock on World Sepsis Day.
|Study Design:||Observational Model: Case-Only
Time Perspective: Prospective
|Official Title:||Surviving Sepsis Campaign. International Multicentre Prevalence Study on Sepsis.|
- 28-Day Mortality [ Time Frame: one week ] [ Designated as safety issue: No ]
- Organ Failure [ Time Frame: one week ] [ Designated as safety issue: No ]
- Length of Stay in the Hospital [ Time Frame: one week ] [ Designated as safety issue: No ]
|Study Start Date:||November 2013|
|Study Completion Date:||January 2014|
|Primary Completion Date:||November 2013 (Final data collection date for primary outcome measure)|
De--‐identified patient--‐level data will be collected on patients presenting to a participating intensive care unit or emergency department with severe sepsis or septic shock over a 24 hour period from 00:00 to 24:00 November 07, 2013. De--‐identified data that is already collected as part of routine clinical care will be collected for this study. Data to be collected includes hospital and ICU characteristics, patient characteristics, severity of illness, and adherence to SSC bundle elements and mortality. It will take between 30--‐60 minutes to collect and enter data for each patient admitted with severe sepsis or septic shock over the 24 hours study period.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01943747
|All centres willing to contribute are welcome.|
|Principal Investigator:||Andrew RHODES, MD, PhD||European Society of Intensive Care Medicine|